Carbapenem-Resistant Enterobacteriaceae
- PMID: 28457352
- PMCID: PMC5412586
- DOI: 10.1016/j.cll.2017.01.005
Carbapenem-Resistant Enterobacteriaceae
Abstract
Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as a major threat. Commonly used antibiotics are generally inactive against CRE. Therefore, timely detection of CRE is of paramount importance. Among CRE, those producing carbapenem-hydrolyzing β-lactamase enzymes (carbapenemase-producing Enterobacteriaceae) are particularly of concern because they tend to spread, and treatment is difficult. The carbapenemase groups most commonly encountered include KPC, NDM, and OXA-48. Treatment options are limited and include combinations of polymyxins, tigecycline, aminoglycosides, or carbapenems; newer agents with activity against CRE and better safety profiles are becoming available and will likely emerge as the preferred therapy.
Keywords: Carbapenemase; KPC; Rapid diagnosis.
Copyright © 2017 Elsevier Inc. All rights reserved.
Conflict of interest statement
Y.D. has served on advisory boards for Meiji, Achaogen, Allergan, Curetis, and has received research funding from The Medicines Company for a study unrelated to this work. A.I declares no conflicts of interest.
Figures
Similar articles
-
Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.Clin Infect Dis. 2017 Feb 1;64(3):257-264. doi: 10.1093/cid/ciw741. Epub 2016 Nov 9. Clin Infect Dis. 2017. PMID: 28013264 Free PMC article.
-
Carbapenemase-producing Enterobacteriaceae.Semin Respir Crit Care Med. 2015 Feb;36(1):74-84. doi: 10.1055/s-0035-1544208. Epub 2015 Feb 2. Semin Respir Crit Care Med. 2015. PMID: 25643272 Free PMC article. Review.
-
In vitro susceptibility of β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline.J Antibiot (Tokyo). 2016 Aug;69(8):600-4. doi: 10.1038/ja.2016.73. Epub 2016 Jun 29. J Antibiot (Tokyo). 2016. PMID: 27353166
-
[Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].Med Monatsschr Pharm. 2014 May;37(5):162-72; quiz 173-4. Med Monatsschr Pharm. 2014. PMID: 24908928 Review. German.
-
What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.Int J Antimicrob Agents. 2011 May;37(5):415-9. doi: 10.1016/j.ijantimicag.2011.01.012. Epub 2011 Mar 22. Int J Antimicrob Agents. 2011. PMID: 21429716
Cited by
-
Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015.Infect Drug Resist. 2019 Jul 16;12:2113-2123. doi: 10.2147/IDR.S208231. eCollection 2019. Infect Drug Resist. 2019. PMID: 31406467 Free PMC article.
-
NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.Clin Microbiol Rev. 2019 Jan 30;32(2):e00115-18. doi: 10.1128/CMR.00115-18. Print 2019 Mar 20. Clin Microbiol Rev. 2019. PMID: 30700432 Free PMC article. Review.
-
What an Escherichia coli Mutant Can Teach Us About the Antibacterial Effect of Chlorophyllin.Microorganisms. 2019 Feb 22;7(2):59. doi: 10.3390/microorganisms7020059. Microorganisms. 2019. PMID: 30813305 Free PMC article.
-
A systematic review and meta-analysis of carbapenem resistance and its possible treatment options with focus on clinical Enterobacteriaceae: Thirty years of development in Pakistan.Heliyon. 2024 Mar 17;10(7):e28052. doi: 10.1016/j.heliyon.2024.e28052. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38596009 Free PMC article.
-
Distribution of NDM1 Carbapenemase-Producing Proteeae Strains on High-Risk Hospital Wards.Infect Drug Resist. 2020 Dec 31;13:4751-4761. doi: 10.2147/IDR.S280977. eCollection 2020. Infect Drug Resist. 2020. PMID: 33408490 Free PMC article.
References
-
- Epson EE, Pisney LM, Wendt JM, et al. Carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-β-lactamase at an acute care hospital, Colorado, 2012. Infect Control Hosp Epidemiol. 2014;35:390–397. - PubMed
-
- Lyman M, Walters M, Lonsway D, Rasheed K, Limbago B, Kallen A. Notes from the field: Carbapenem-resistant Enterobacteriaceae producing OXA-48-like carbapenemases--United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2015;64:1315–1316. - PubMed
-
- Centers for Disease C, Prevention. Ten great public health achievements--United States, 1900–1999. MMWR Morb Mortal Wkly Rep. 1999;48:241–243. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical